Zhitong Finance and Economics Network
Zhitong Financial APP learned that on September 24th111 Inc (YI.US)The third China Internet Pharmaceutical and Health Summit Forum was hosted in Shanghai. With the theme of "inclusive digital link technology", the summit brought together many elites in the field of medicine and health, such as pharmaceutical executives and investment celebrities. During the summit, 111 Inc andGuangzhou Xiangxue PharmaceuticalJoint Stock Co., Ltd. (referred to as "Xiangxue Pharmaceutical") formally signed a strategic cooperation agreement, the two sides will deepen cooperation in the field of "Internet + Medicine" and realize the value sharing of industrial chain innovation and digital exploration in the field of traditional Chinese medicine.
The Innovation of docking Industry chain promotes the omni-channel commercialization of traditional Chinese Medicine
According to the agreement, 111 Inc will become the omni-channel business partner of Xiangxue Pharmaceutical, through the integration of intelligent supply chain, big data, digital marketing, cloud service and other technologies, help Xiangxue Pharmaceutical's rich traditional Chinese medicine products expand and infiltrate into the broader online and offline market in a more efficient way.
Xiangxue Pharmaceutical has always focused on large health industries in the fields of new traditional Chinese medicine, proprietary Chinese medicine, functional health products, biomedical engineering, life science research, and so on. It has gradually developed into a leading modern enterprise of traditional Chinese medicine with independent intellectual property rights, independent brands and independent innovation capabilities. At present, Xiangxue has set up 60 + subsidiaries in major cities across the country, established a sound sales network, and invested in the construction of large-scale GAP medicine planting base and GMP production base, creating a complete industrial chain of traditional Chinese medicine resources development, new drug R & D and creation, traditional Chinese medicine advanced manufacturing, modern logistics and distribution, realizing the integrated innovation of the whole industry chain, with annual sales exceeding 3 billion yuan.
As a pioneer and leader in the field of "Internet + Medicine", 111 Inc has built China's largest online and offline integrated medical and health platform by means of digital science and technology, covering 280000 pharmacy terminals across the country. In particular, Xiangxue Pharmaceutical can not reach the 3-6 tier cities, the pharmacy coverage rate is more than 63%. Through this cooperation, 111 Inc's omni-channel drug commercialization platform is fully docked with Xiangxue Pharmaceutical's innovation resources of the whole industry chain, which will help Xiangxue Pharmaceutical to achieve a substantial increase in traditional Chinese medicine sales. and further enhance 111 Inc's ability to efficiently link patients and pharmaceutical companies, and finally achieve ecological win-win.
Tan Guanghua, general manager of Xiangxue Pharmaceutical Marketing Center, said that 111 Inc, an Internet pharmaceutical health leader, has established strong advantages in the intelligent supply chain, big data, and omni-channel drug commercialization capabilities. This strategic cooperation with 111 Inc integrates the most advantageous resources of both sides, and is full of confidence and expectation for achieving the goal of substantial increase in annual sales.
Deep empowering to explore Digital Health Service of traditional Chinese Medicine
Since 2020, the raging health events have further accelerated the development of the Internet medicine and health industry. through Internet technology and channels, the realization of digital transformation and upgrading has become the inevitable choice and consensus for the development of pharmaceutical companies. It is understood that this strategic cooperation, in addition to the commercialization of omni-channel drugs, 111 Inc will use Internet thinking and means to further promote Xiangxue Pharmaceutical to realize the digital development of traditional Chinese medicine health services.
Xiangxue Pharmaceutical has always regarded the development of traditional Chinese medicine and the realization of traditional Chinese medicine modernization as a long-term development strategy, and has become a new benchmark in the digitization of traditional Chinese medicine, such as traceability, production and circulation, quality standards, safety evaluation, efficacy evaluation and so on. As a leading enterprise in Internet medicine and health, 111 Inc has an industry leading edge in patient service, digital marketing, brand operation, patient health management and supply chain management in the field of Internet medicine. In June 2020, 111 Inc ranked TOP1 in the pharmaceutical APP and achieved more than 99% customer satisfaction with his high quality of service.
Zhu Pengcheng, chief operating officer of 111 Inc, said that he is full of confidence in the cooperation between the two sides and expects the two sides to give further play to their respective advantages, benefit each other, and make joint efforts to carry forward the traditional Chinese medicine culture. 111 Inc will make full use of the advantages of digital medicine and health platform, combined with Xiangxue Pharmaceutical's innovative resources in the digitization of traditional Chinese medicine, and empower each other in big data application, online marketing of traditional Chinese medicine, brand co-building, user health management, and so on. Benefit more patients and create greater commercial and social value.